The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy

被引:0
作者
R. Mazzola
S. Fersino
A. Fiorentino
F. Ricchetti
N. Giaj Levra
G. Di Paola
G. Sicignano
S. Naccarato
R. Ruggieri
F. Alongi
机构
[1] Sacro Cuore Don Calabria Hospital,Radiation Oncology
[2] University of Palermo,Radiation Oncology School
[3] University of Palermo,Statistic Sciences Faculty
来源
Clinical and Translational Oncology | 2016年 / 18卷
关键词
Prostate cancer; Radiotherapy; Hypofractionation; Toxicity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:317 / 321
页数:4
相关论文
共 154 条
[1]  
Arcangeli G(2010)A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer Int J Radiat Oncol Biol Phys 78 11-18
[2]  
Saracino B(2005)Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 6132-6138
[3]  
Gomellini S(2012)Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer Int J Radiat Oncol Biol Phys 84 1172-1178
[4]  
Petrongari MG(2010)Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation Int J Radiat Oncol Biol Phys 78 S58-S59
[5]  
Arcangeli S(2012)Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Strahlenther Onkol 188 990-996
[6]  
Sentinelli S(2013)Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer J Clin Oncol 31 3860-3868
[7]  
Lukka H(2011)Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial Int J Radiat Oncol Biol Phys 81 1271-1278
[8]  
Hayter C(2012)Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial Lancet Oncol. 13 43-54
[9]  
Julian JA(2013)Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer Anticancer Res 33 4537-4543
[10]  
Warde P(2009)Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer Int J Radiat Oncol Biol Phys 74 392-398